Literature DB >> 27539243

Therapy: Gastrointestinal risks of incretin-based drugs.

Claire Greenhill.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27539243     DOI: 10.1038/nrendo.2016.140

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

1.  Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Authors:  Laurent Azoulay; Kristian B Filion; Robert W Platt; Matthew Dahl; Colin R Dormuth; Kristin K Clemens; Madeleine Durand; Nianping Hu; David N Juurlink; J Michael Paterson; Laura E Targownik; Tanvir C Turin; Pierre Ernst; Samy Suissa; Colin R Dormuth; Brenda R Hemmelgarn; Gary F Teare; Patricia Caetano; Dan Chateau; David A Henry; J Michael Paterson; Jacques LeLorier; Adrian R Levy; Pierre Ernst; Robert W Platt; Ingrid S Sketris
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

2.  Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus.

Authors:  Jean-Luc Faillie; Oriana H Yu; Hui Yin; Dominique Hillaire-Buys; Alan Barkun; Laurent Azoulay
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.